Article Information
History
- December 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Todd C. Lee, MD MPH FIDSA1,2,3,*,
- Simone Vigod, MD MSc4,
- Émilie Bortolussi-Courval, BScN3,
- Ryan Hanula, BSc3,
- David R. Boulware, MD MPH5,
- Eric J. Lenze, MD6,
- Angela M. Reiersen, MD MPE6 and
- Emily G. McDonald, MD MSc2,3,7
- 1Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Canada
- 2Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Canada
- 3Division of Experimental Medicine, Department of Medicine, McGill University
- 4Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto and Women’s College Hospital, Toronto, Ontario, Canada
- 5Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
- 6Department of Psychiatry, School of Medicine, Washington University in Saint Louis, St. Louis, Missouri, USA
- 7Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Canada
- ↵*Corresponding author:
Todd C. Lee MD MPH, 1001 Decarie Blvd E5-1820, Montreal, QC, H4A3S1, todd.lee{at}mcgill.ca
Posted December 21, 2021.
Fluvoxamine for Outpatient COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-Analysis
